The rarity of disease states coupled with novel medication mechanisms and high costs lead to complexities in accessing treatment and optimizing outcomes.
Pamela Koerner, PharmD
Advertisement
Articles by Pamela Koerner, PharmD
Advertisement
Latest Updated Articles
Rare Pharmacy Emerges From Specialty: Part 1Published: July 30th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updated Hypertension Guidelines Are Here
2
FDA Approves Reformulated Ranitidine After 5-Year Absence
3
Carefully Consider Ethical Implications of Artificial Intelligence Use in Pharmacy
4
Application of the Age-Friendly 4M’s Movement Across Different Areas of Pharmacy
5
